StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Perspective Therapeutics's gross margin for the twelve months ending Jun 30, 2022 was 0.0%. For fiscal 2022 it was 0.0%, against 50.9% the year before. The highest annual figure on record is 52.9% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2022Jun 30, 20220.0%−50.9
FY2021Jun 30, 202150.9%−2.0
FY2020Jun 30, 202052.9%+11.3
FY2019Jun 30, 201941.7%+10.6
FY2018Jun 30, 201831.1%+13.5
FY2017Jun 30, 201717.6%+14.9
FY2016Jun 30, 20162.7%−0.9
FY2015Jun 30, 20153.6%+8.3
FY2014Jun 30, 2014-4.7%−8.0
FY2013Jun 30, 20133.3%−10.5
FY2012Jun 30, 201213.9%−8.2
FY2011Jun 30, 201122.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2022CQ2 2022Jun 30, 202237.0%−12.7
Q3 FY2022CQ1 2022Mar 31, 202249.5%−2.9
Q2 FY2022CQ4 2021Dec 31, 202143.3%−6.1
Q1 FY2022CQ3 2021Sep 30, 202140.1%−12.1
Q4 FY2021CQ2 2021Jun 30, 202149.7%+2.7
Q3 FY2021CQ1 2021Mar 31, 202152.4%−6.9
Q2 FY2021CQ4 2020Dec 31, 202049.5%−0.9
Q1 FY2021CQ3 2020Sep 30, 202052.3%−1.1
Q4 FY2020CQ2 2020Jun 30, 202047.0%+1.3
Q3 FY2020CQ1 2020Mar 31, 202059.2%+13.6
Q2 FY2020CQ4 2019Dec 31, 201950.4%+10.2
Q1 FY2020CQ3 2019Sep 30, 201953.4%+19.8
Q4 FY2019CQ2 2019Jun 30, 201945.7%+18.1
Q3 FY2019CQ1 2019Mar 31, 201945.7%+7.0
Q2 FY2019CQ4 2018Dec 31, 201840.2%+5.6
Q1 FY2019CQ3 2018Sep 30, 201833.5%+11.7
Q4 FY2018CQ2 2018Jun 30, 201827.6%−8.7
Q3 FY2018CQ1 2018Mar 31, 201838.7%+15.9
Q2 FY2018CQ4 2017Dec 31, 201734.6%+34.7
Q1 FY2018CQ3 2017Sep 30, 201721.9%+17.4
Q4 FY2017CQ2 2017Jun 30, 201736.4%+40.6
Q3 FY2017CQ1 2017Mar 31, 201722.9%+17.3
Q2 FY2017CQ4 2016Dec 31, 2016-0.1%−2.6
Q1 FY2017CQ3 2016Sep 30, 20164.4%−2.1
Q4 FY2016CQ2 2016Jun 30, 2016-4.3%−19.6
Q3 FY2016CQ1 2016Mar 31, 20165.5%+0.7
Q2 FY2016CQ4 2015Dec 31, 20152.5%–
Q1 FY2016CQ3 2015Sep 30, 20156.6%–
Q4 FY2015CQ2 2015Jun 30, 201515.3%–
Q3 FY2015CQ1 2015Mar 31, 20154.8%–

More Perspective Therapeutics figures

See a number that looks wrong?